SCHEMBL5161753

SCHEMBL5161753

C=CC1=C(C(=O)OC(c2ccccc2)c2ccccc2)N2C(=O)C(NC(=O)/C(=N\O)c3csc(N)n3)[C@H]2SC1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 7/20 0.75
▸ MAPT P10636 5/20 0.75
▸ ABCC4 O15439 2/20 0.75
▸ CNR1 P21554 1/20 0.75
▸ CTDSP1 Q9GZU7 1/20 0.75
▸ APEX1 P27695 3/20 0.63
▸ APAF1 O14727 2/20 0.63
▸ LMNA P02545 2/20 0.63
▸ L3MBTL1 Q9Y468 2/20 0.63
▸ TSHR P16473 1/20 0.63
▸ PLCG1 P19174 1/20 0.63
▸ ABCC2 Q92887 1/20 0.63
▸ SIRT5 Q9NXA8 1/20 0.63
▸ PSMD14 O00487 1/20 0.63
▸ MMP2 P08253 1/20 0.63
▸ HPGD P15428 2/20 0.54
▸ NR1I2 O75469 5/20 0.50
▸ HTR2C P28335 1/20 0.50
▸ PTGS1 P23219 2/20 0.49
▸ ABCB11 O95342 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5161757 1.00 TDP1 (0.75) TDP1MAPTABCC4CNR1CTDSP1
SCHEMBL5484474 1.00 TDP1 (0.75) TDP1MAPTABCC4CNR1CTDSP1
Bromide SCHEMBL10529250 0.99 TDP1 (0.74) TDP1MAPTABCC4CNR1CTDSP1
Bromide SCHEMBL5161813 0.99 TDP1 (0.74) TDP1MAPTABCC4CNR1CTDSP1
SCHEMBL9482053 0.92 TDP1 (0.65) TDP1MAPTABCC4CNR1CTDSP1
SCHEMBL9482056 0.92 TDP1 (0.65) TDP1MAPTABCC4CNR1CTDSP1
SCHEMBL10893639 0.92 TDP1 (0.62) TDP1MAPTABCC4CNR1CTDSP1
SCHEMBL10893625 0.92 TDP1 (0.62) TDP1MAPTABCC4CNR1CTDSP1
SCHEMBL10893628 0.92 TDP1 (0.62) TDP1MAPTABCC4CNR1CTDSP1
SCHEMBL9481965 0.91 TDP1 (0.71) TDP1MAPTABCC4CNR1CTDSP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1749013-A2 STABLE AMORPHOUS CEFDINIR ABBOTT LABORATORIES (US) 2007-02-07 — — EP disclosed
US-20060069079-A1 Stable amorphous cefdinir ABBOTT LABORATORIES 2006-03-30 — — US disclosed
US-20060029674-A1 Stable amorphous Cefdinir ABBOTT LABORATORIES 2006-02-09 — — US disclosed
WO-2005100368-A2 STABLE AMORPHOUS CEFDINIR ABBOTT LABORATORIES (US) 2005-10-27 — — WO disclosed
US-20050113355-A1 Cefdinir pyridine salt ABBOTT LABORATORIES 2005-05-26 — — US disclosed
US-20050059819-A1 Cefdinir pyridine salt ABBOTT LABORATORIES 2005-03-17 — — US disclosed
EP-0105459-B1 SYN-ISOMER OF 7-SUBSTITUTED-3-VINYL-3-CEPHEM COMPOUNDS, PROCESSES FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-03-22 — — EP disclosed
EP-0304019-A2 Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid (syn isomer) FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-02-22 — — EP disclosed
US-4559334-A MICROBIOCIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-12-17 — — US disclosed
EP-0105459-A2 Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-04-18 — — EP disclosed
Send feedback